At Pathway Diagnostics, our mission is simple and uncompromising: to deliver answers clinicians can trust and patients can act on.
At Pathway Diagnostics, our mission is simple and uncompromising: to deliver answers clinicians can trust and patients can act on.
Thank you for trusting Pathway Diagnostics. We are honored to support you and your patients with dependable results, thoughtful communication, and genuine care—case after case.
Every specimen entrusted to us represents a person, a family, and a set of decisions that cannot wait. That responsibility shapes everything we do—from rigorous pre-analytic handling and evidence-based workflows to clear, clinically focused reports.
We partner closely with surgeons, oncologists, gastroenterologists, radiologists, and primary care teams to ensure that our pathology adds real value at the point of care. Our services span comprehensive histopathology, cytopathology, immunohistochemistry, special stains, hematopathology, flow cytometry, and referral pathways for molecular and cytogenetic testing—all supported by robust quality systems aligned with international best practices and UAE regulatory standards.
Speed matters, but clarity and accuracy come first. We emphasize concise diagnoses, pertinent synoptic elements, and practical commentaries that guide management. When needed, we facilitate second opinions and multidisciplinary discussions to resolve the toughest cases. We are also investing in digital pathology and validated decision-support tools to enhance consistency and turnaround without compromising the human judgment at the heart of our specialty.
Yasin K. Ahmed, MD, FCAP, ABMS
Medical Director, Pathway Diagnostics
Abu Dhabi, United Arab Emirates
National Reference Laboratory (NRL), a M42 partner, is focused on increasing the quality, spectrum, coverage and overall efficiency of laboratory testing in the UAE and GCC region. NRL implements international best-practice laboratory processes and aims to set the benchmark for quality standards in the region.
